430 related articles for article (PubMed ID: 14753741)
1. Isolation of a human homolog of osteoclast inhibitory lectin that inhibits the formation and function of osteoclasts.
Hu YS; Zhou H; Myers D; Quinn JM; Atkins GJ; Ly C; Gange C; Kartsogiannis V; Elliott J; Kostakis P; Zannettino AC; Cromer B; McKinstry WJ; Findlay DM; Gillespie MT; Ng KW
J Bone Miner Res; 2004 Jan; 19(1):89-99. PubMed ID: 14753741
[TBL] [Abstract][Full Text] [Related]
2. A novel osteoblast-derived C-type lectin that inhibits osteoclast formation.
Zhou H; Kartsogiannis V; Hu YS; Elliott J; Quinn JM; McKinstry WJ; Gillespie MT; Ng KW
J Biol Chem; 2001 May; 276(18):14916-23. PubMed ID: 11278931
[TBL] [Abstract][Full Text] [Related]
3. Osteoclast inhibitory lectin, a family of new osteoclast inhibitors.
Zhou H; Kartsogiannis V; Quinn JM; Ly C; Gange C; Elliott J; Ng KW; Gillespie MT
J Biol Chem; 2002 Dec; 277(50):48808-15. PubMed ID: 12374791
[TBL] [Abstract][Full Text] [Related]
4. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
5. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
Nakamura A; Ly C; Cipetić M; Sims NA; Vieusseux J; Kartsogiannis V; Bouralexis S; Saleh H; Zhou H; Price JT; Martin TJ; Ng KW; Gillespie MT; Quinn JM
Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328
[TBL] [Abstract][Full Text] [Related]
6. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
[TBL] [Abstract][Full Text] [Related]
7. Characterization of sugar binding by osteoclast inhibitory lectin.
Gange CT; Quinn JM; Zhou H; Kartsogiannis V; Gillespie MT; Ng KW
J Biol Chem; 2004 Jul; 279(28):29043-9. PubMed ID: 15123656
[TBL] [Abstract][Full Text] [Related]
8. Cloning and identification of human Sca as a novel inhibitor of osteoclast formation and bone resorption.
Choi SJ; Devlin RD; Menaa C; Chung H; Roodman GD; Reddy SV
J Clin Invest; 1998 Oct; 102(7):1360-8. PubMed ID: 9769328
[TBL] [Abstract][Full Text] [Related]
9. Bidirectional signaling between stromal and hemopoietic cells regulates interleukin-1 expression during human osteoclast formation.
Haynes DR; Atkins GJ; Loric M; Crotti TN; Geary SM; Findlay DM
Bone; 1999 Sep; 25(3):269-78. PubMed ID: 10495130
[TBL] [Abstract][Full Text] [Related]
10. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
[TBL] [Abstract][Full Text] [Related]
11. Knockout of the murine prostaglandin EP2 receptor impairs osteoclastogenesis in vitro.
Li X; Okada Y; Pilbeam CC; Lorenzo JA; Kennedy CR; Breyer RM; Raisz LG
Endocrinology; 2000 Jun; 141(6):2054-61. PubMed ID: 10830290
[TBL] [Abstract][Full Text] [Related]
12. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-33 is expressed in differentiated osteoblasts and blocks osteoclast formation from bone marrow precursor cells.
Schulze J; Bickert T; Beil FT; Zaiss MM; Albers J; Wintges K; Streichert T; Klaetschke K; Keller J; Hissnauer TN; Spiro AS; Gessner A; Schett G; Amling M; McKenzie AN; Horst AK; Schinke T
J Bone Miner Res; 2011 Apr; 26(4):704-17. PubMed ID: 20939024
[TBL] [Abstract][Full Text] [Related]
14. Basic fibroblast growth factor inhibits osteoclast-like cell formation.
Jimi E; Shuto T; Ikebe T; Jingushi S; Hirata M; Koga T
J Cell Physiol; 1996 Aug; 168(2):395-402. PubMed ID: 8707875
[TBL] [Abstract][Full Text] [Related]
15. Thiazolidinediones inhibit osteoclast-like cell formation and bone resorption in vitro.
Okazaki R; Toriumi M; Fukumoto S; Miyamoto M; Fujita T; Tanaka K; Takeuchi Y
Endocrinology; 1999 Nov; 140(11):5060-5. PubMed ID: 10537132
[TBL] [Abstract][Full Text] [Related]
16. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of osteoclast precursors that differentiate into osteoclasts on calvarial cells within a short period of time.
Tsurukai T; Takahashi N; Jimi E; Nakamura I; Udagawa N; Nogimori K; Tamura M; Suda T
J Cell Physiol; 1998 Oct; 177(1):26-35. PubMed ID: 9731742
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2, interleukin 1alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro.
Lader CS; Flanagan AM
Endocrinology; 1998 Jul; 139(7):3157-64. PubMed ID: 9645689
[TBL] [Abstract][Full Text] [Related]
19. Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells.
Yang CR; Wang JH; Hsieh SL; Wang SM; Hsu TL; Lin WW
Cell Death Differ; 2004 Jul; 11 Suppl 1():S97-107. PubMed ID: 15002040
[TBL] [Abstract][Full Text] [Related]
20. T-cells mediate an inhibitory effect of interleukin-4 on osteoclastogenesis.
Mirosavljevic D; Quinn JM; Elliott J; Horwood NJ; Martin TJ; Gillespie MT
J Bone Miner Res; 2003 Jun; 18(6):984-93. PubMed ID: 12817750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
